Scott Tarriff, President and CEO, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 135,710 shares at $77.58 ($6.3M) on 2015-07-01, disclosed to the SEC on 2015-07-02.
Scheduled sale ($6.3M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.00 | 120,000 | $5.0M | 80.1% |
| 2 | $77.58 | 3,710 | $288K | 4.6% |
| 3 | $78.98 | 6,015 | $475K | 7.6% |
| 4 | $80.28 | 1,483 | $119K | 1.9% |
| 5 | $81.50 | 4,502 | $367K | 5.8% |
| Total | $46.34 avg | 135,710 |
| $6.3M |
| 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |